Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%-To The Moon - Tiger Brokers Online Investing Community - To The Moon

2
Comment
Favorite

Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%

Tiger Newspress01-07 23:15

Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.

Eli Lilly has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.

A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.'s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.'s competing platform, final prices are even lower after the application of promotional coupons.

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

2

Report

Comment

empty

No comments yet

Most Discussed

7x24

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1146401006?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-07 23:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146401006","market":"us","top_or_hot":-1,"title":"Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%","media":"Tiger Newspress","content":"<html><head></head><body><p>Weight-loss drugmakers&#39; stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/68bb1b65fadad1a3b7a308ecfe18a35e\" title=\"\" tg-width=\"534\" tg-height=\"453\"/></p><p><strong><a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a></strong> has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.</p><p>A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.&#39;s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.&#39;s competing platform, final prices are even lower after the application of promotional coupons.</p><p>Danish drugmaker <strong><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a></strong> is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2026-01-07 23:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Weight-loss drugmakers&#39; stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/68bb1b65fadad1a3b7a308ecfe18a35e\" title=\"\" tg-width=\"534\" tg-height=\"453\"/></p><p><strong><a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a></strong> has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.</p><p>A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.&#39;s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.&#39;s competing platform, final prices are even lower after the application of promotional coupons.</p><p>Danish drugmaker <strong><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a></strong> is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VKTX","symbol_name":"Viking Therapeutics, Inc.","start_time":0,"source_url":"","article_id":"1146401006","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146401006","pubTimestamp":1767798955,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VKTX":"Viking Therapeutics, Inc.","RHHBY":"罗氏控股","AMGN":"安进","GPCR":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","LLY":"礼来","NVO":"诺和诺德","PFE":"辉瑞"},"translate_title":"减肥制药商的股价上涨。Structure Therapeutics上涨5%；礼来涨4%创历史新高；安进上涨3%；罗氏、Novo上涨约2%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":2,"PFE":2,"VKTX":2,"RHHBY":2,"AMGN":2,"GPCR":2,"LLY":2},"content_text":"Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.Eli Lilly has significantly reduced the price of its blockbuster weight-loss and diabetes medication, Mounjaro, in China, escalating its competitive battle with Novo Nordisk A/S and domestic competitors.A one-month supply of the lowest Mounjaro dosage is now priced at 599 yuan ($85.79) on JD.com Inc.'s online marketplace, a dramatic reduction of nearly 70% from its initial launch price of 1,758 yuan last year. The highest dose now sells for 1,599 yuan, down sharply from 4,758 yuan. On Alibaba Group Holding Ltd.'s competing platform, final prices are even lower after the application of promotional coupons.Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 milligrams and 4 mg at $149 per month for self-paying patients in an intensely competitive weight-loss drug market.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}